Data / Form D filings / Empirico Inc.
Empirico Inc.: Form D filings
Empirico Inc., a biotechnology company in San Diego, CA, filed 3 Form D notices with the SEC between 2018 and 2023. The latest, on March 23, 2023, reports $45.2 million sold of a $55.2 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4660 LA JOLLA VILLAGE DRIVE, SUITE 100, San Diego, CA, 92122
- Phone
- (347) 725-0022
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1758846
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 23, 2023 | New notice | $55,222,199 | $45,222,197 | $10,000,002 | 4 | Mar 9, 2023 | sec.gov |
| Dec 31, 2019 | New notice | $16,999,999 | $16,999,999 | 3 | Dec 20, 2019 | sec.gov | |
| Nov 13, 2018 | New notice | $12,549,999 | $12,549,999 | 5 | Nov 1, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| John Hamer | Director | |
| Omri Gottesman | Executive Officer, Director | |
| Shannon Bruse | Executive Officer, Director | |
| Dennis Langer | Director | |
| Kolluri Swaroop | Director | |
| Brian Cajes | Executive Officer |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Mar 20, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Empirico Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.